Facial Palsy News and Research

RSS

Adding antiviral agent to corticosteroids to treat facial paralysis not linked to improved recovery

Adding an antiviral agent to corticosteroids for treatment of Bell's palsy (a condition characterized by partial facial paralysis) is not associated with improved recovery of facial movement function, according to a meta-analysis of previously published studies in the June issue of Archives of Otolaryngology-Head & Neck Surgery.

16 Jun 2009

Lyme disease emerging in Canada

Lyme disease is emerging in Canada, and is expected to increase with climate change, but effective, enhanced surveillance and clinician awareness will be key to minimizing the impact of the disease, write researchers in a review in CMAJ (Canadian Medical Association Journal).

9 Jun 2009

Antibiotic Minocycline shows potential as stroke treatment

People treated with the drug minocycline within six to 24 hours after a stroke had significantly fewer disabilities, according to a study published in the October 2, 2007, issue of Neurology®, the medical journal of the American Academy of Neurology.

2 Oct 2007

A sudden increase in the number of British cases of Lyme disease

Lyme disease, an infection carried by ticks causes a rash and stiffness in the joints and, if left unchecked, it can affect the central nervous system, causing tingling in hands and feet, or facial palsy. In the worst cases the disease can also affect the heart, liver and spleen and even lead to encephalitis, which can kill.

29 May 2005

Stroke severity is the predominant predictor of discharge destination

An article in the July issue of the Archives of Neurology reports that increasing stroke severity, as measured by the National Institutes of Health Stroke Scale, increases the likelihood that stroke patients who are treated with the rt-PA clot-dissolving drug will be discharged to rehabilitation or nursing homes, rather than to their own homes.

20 Jul 2004